Palatin Technologies

+$0.0018 (+0.30%) Today
$0.00 (0.00%) As of 11:59 PM UTC after-hours

Why Robinhood?

You can buy or sell PTN and other stocks, options, and ETFs commission-free!

About PTN

Palatin Technologies, Inc., also called Palatin Technologies, is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, a peptide melanocortin receptor 4 agonist for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD).

CEO
Carl Spana
Employees
20
Headquarters
Cranbury, New Jersey
Founded
1986

PTN Key Statistics

Market Cap
140.33M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.78M
High Today
$0.6249
Low Today
$0.61
Open Price
$0.6249
Volume
1.01M
52 Week High
$1.30
52 Week Low
$0.375

PTN Earnings

-$0.04
-$0.03
-$0.01
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Sep 23, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure